Beyond efficacy and safety-the need for convenient and cost-effective iron therapy in health care
| Autor: | Sunil Bhandari |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Cost effectiveness iron carboxymaltose (Ferinject) iron isomaltoside 1000 (Monofer) National Service Framework ferumoxytol (Feraheme) Dosing schedules Iron Isomaltoside 1000 Health care cost medicine In patient Intensive care medicine Transplantation anaemia business.industry medicine.disease Surgery low-molecular-weight iron dextran (Cosmofer) Nephrology Supplement Article iron sucrose (Venofer) business Iron therapy chronic kidney disease Kidney disease patient choice |
| Zdroj: | NDT Plus |
| ISSN: | 1753-0784 |
| Popis: | The National Service Framework advocates correction of anaemia in patients with chronic kidney disease (CKD). Oral iron is insufficient, while intravenous (IV) supplementation replenishes and maintains iron stores. Previously, effective delivery of iron therapy using available parenteral preparations has been hampered by dosing schedules and the need in some cases of a test dose. The introduction in Europe of newer iron preparations, including iron isomaltoside 1000 (Monofer) and iron carboxymaltose (Ferinject), now offers a potentially safe, effective and time-efficient method of outpatient iron repletion. This may potentially lead to better cost-effectiveness in a resource-limited service. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|